NCT04179474: Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
- State
- Completed
- Phase
- Phase 1
- People
- 40 taking part
- Started
- 26 Sep 2019
- Primary completion
- 23 Dec 2019
- Arms
- Part 1 (Intervention A then B then D)
- Results
- Posted on the registry
- 26 Sep 2019: Trial started
- 27 Nov 2019: Trial registered
- 23 Dec 2019: Trial completed
- 10 Mar 2021: Trial results posted